14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.48 $4.41 Friday, 3rd May 2024 EVAX stock ended at $3.95. This is 1.54% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.64% from a day low at $3.85 to a day high of $3.99.
90 days $2.82 $4.74
52 weeks $0.470 $13.55

Historical Evaxion Biotech A/S prices

Date Open High Low Close Volume
Sep 28, 2023 $0.92 $0.92 $0.81 $0.85 34 472
Sep 27, 2023 $0.82 $0.88 $0.750 $0.84 70 260
Sep 26, 2023 $0.760 $0.790 $0.693 $0.790 166 122
Sep 25, 2023 $0.770 $0.778 $0.680 $0.738 53 086
Sep 22, 2023 $0.82 $0.84 $0.761 $0.767 217 528
Sep 21, 2023 $0.720 $0.91 $0.650 $0.750 1 161 177
Sep 20, 2023 $0.553 $0.720 $0.540 $0.680 1 615 254
Sep 19, 2023 $0.600 $0.670 $0.470 $0.480 458 701
Sep 18, 2023 $0.730 $0.790 $0.591 $0.598 403 825
Sep 15, 2023 $0.738 $0.766 $0.650 $0.752 93 788
Sep 14, 2023 $0.729 $0.756 $0.729 $0.730 12 457
Sep 13, 2023 $0.790 $0.799 $0.730 $0.750 35 959
Sep 12, 2023 $0.80 $0.80 $0.750 $0.787 75 048
Sep 11, 2023 $0.700 $0.781 $0.635 $0.781 401 072
Sep 08, 2023 $0.740 $0.740 $0.670 $0.682 52 240
Sep 07, 2023 $0.770 $0.790 $0.710 $0.711 76 157
Sep 06, 2023 $0.81 $0.81 $0.750 $0.775 47 800
Sep 05, 2023 $0.90 $0.90 $0.760 $0.800 113 028
Sep 01, 2023 $0.85 $0.86 $0.81 $0.81 30 541
Aug 31, 2023 $0.88 $0.89 $0.83 $0.83 21 357
Aug 30, 2023 $0.87 $0.89 $0.85 $0.85 34 655
Aug 29, 2023 $0.90 $0.90 $0.760 $0.90 145 655
Aug 28, 2023 $0.90 $0.92 $0.86 $0.88 50 239
Aug 25, 2023 $0.91 $0.95 $0.90 $0.90 13 614
Aug 24, 2023 $0.98 $0.98 $0.90 $0.95 33 472
Click to get the best stock tips daily for free!

About Evaxion Biotech A/S

Evaxion Biotech A/S Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various... EVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT